Clinical Trials Directory

Trials / Completed

CompletedNCT02731703

Conventional, Overdenture and Palateless Overdenture Oral Health Impact Comparison Study

Evaluation of Patient Satisfaction Comparing Conventional, Overdenture and Palateless Overdenture Using Guided Maxillary Implant Placement

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study will identify and enroll patients already scheduled to receive guided maxillary implant placement with palateless overdenture. Standard clinical practice will be followed for this multi-stage process. The study purpose is to evaluate the degree of satisfaction during the standard progression in order to determine at which post edentulous stage patients achieve maximum satisfaction using the Oral Health Impact Profile 49 (OHIP 49).

Detailed description

The OHIP 49 will be administered at pre-treatment (edentulous condition) and after each visit (i.e., newly fabricated conventional denture, conversion to a 4 implant retained overdenture and finally a 4 implant retained palateless overdenture). Additionally they will be recalled yearly for 5 years. Participants will have an interim denture fabricated to be worn for 10-12 weeks. During this time, participants will have 4 implants placed and continue wearing the interim denture. At 8 weeks after implant placement, participants will have locator attachments placed on implants and the interim denture snapped into place, termed the 'overdenture.' After 10-12 weeks of wearing this overdenture, patients will receive a new denture, termed 'final palateless overdenture,' which consists of a denture snapped into the 4 implants without a palate. Participants will be evaluated at a 10-12 week followup from insertion of this prosthesis. Participants will complete questionnaires at each stage of treatment. One year after delivery of the final palateless overdenture and for five consecutive years patients will be asked to return for a follow up appointment. Estimated duration of patient participation is approximately 5 years and 8 months (271 weeks). Estimated time for active clinical treatment is 8 months (32 weeks) with understanding of flexibility based on laboratory fabricated denture frameworks and adjustments needed for approval of esthetics.

Conditions

Interventions

TypeNameDescription
DEVICEOverdenture treatmentConventional, FDA-approved prosthetics will be used in accordance with their labeling and pre-study prescribed standard treatment approach

Timeline

Start date
2016-04-01
Primary completion
2017-08-09
Completion
2023-01-04
First posted
2016-04-07
Last updated
2023-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02731703. Inclusion in this directory is not an endorsement.